학술논문
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial
Document Type
Article
Author
Source
In The Journal of Allergy and Clinical Immunology: In Practice May-June 2019 7(5):1599-1609
Subject
Language
ISSN
2213-2198